This may be due to the fact that HK2, instead of HK1, is frequently upregulated in cancer, and, in addition, the binding of HK2 to the external mitochondrial membrane in a complex with VDAC1 is known to contribute to fuel the glycolytic process (32). The gene discussed is HK1; the disease is cancer.